At a glance
- Originator Kotobuki Seiyaku
- Class Antihypertensives
- Mechanism of Action Angiotensin type 1 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hypertension
Most Recent Events
- 26 May 2001 Discontinued-Preclinical for Hypertension in Japan (PO)
- 31 Jul 1997 Suspended-Preclinical for Hypertension in Japan (PO)
- 17 Oct 1995 New profile